Riskpilot← Back to searchSign inGet full accessNAMSEN LEGESENTER AS
ASActiveOrg 993466972Navarvegen 19, 7820 SpillumGeneral medical practice activities · NACE 8621Est. 20098 employees
Revenue 2025
NOK 3,7M
-2% vs 2024
EBITDA margin
-4.9%
-382% vs 2024
Equity ratio
8.8%
Financial strength
Net profit 2025
NOK -141K
-421% vs 2024
| Revenue | NOK 3,7M | -2% |
| EBITDA | NOK -181K | -382% |
| Net profit | NOK -141K | -421% |
| Total assets | NOK 362K | -25% |
| Equity | NOK 32K | -82% |
| Employees | 8 | — |
Legal name
NAMSEN LEGESENTER AS
Org number
993466972
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
12. januar 2009
Share capital
NOK 136 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Drift av legesenter samt hva naturlig hører til, herunder være aksjonær i andre selskap.
Address
Navarvegen 19, 7820 Spillum
Phone
+4774218080
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 556 | 3 779 | 3 619 | 3 762 | 3 703 |
| Staff expenses | −1 787 | −1 939 | −2 043 | −2 055 | −2 211 |
| EBITDA | 64 | −4 | 118 | 64 | −181 |
| Depreciation & amort. | −103 | −22 | −19 | −7 | −0 |
| EBIT | −39 | −26 | 100 | 57 | −181 |
| Net financials | 0 | −0 | −0 | −0 | −0 |
| Profit before tax | −39 | −26 | 99 | 57 | −181 |
| Tax | −9 | −5 | 22 | 12 | −40 |
| Net profit | −30 | −21 | 77 | 44 | −141 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 472 | 369 | 411 | 480 | 362 |
| Equity | 73 | 52 | 129 | 173 | 32 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 399 | 318 | 282 | 307 | 330 |
| Total debt | 399 | 318 | 282 | 307 | 330 |
EBITDA margin
-4.9%
This company
15.8%
Market median
-131% vs market
20212025
Equity ratio
8.8%
This company
38.2%
Market median
-77% vs market
20212025
Return on equity
-446.4%
This company
18.4%
Market median
-2526% vs market
20212025
Net profit margin
-3.8%
This company
8.1%
Market median
-147% vs market
20212025
Asset turnover
10.23×
This company
1.12×
Market median
+813% vs market
20212025
Debt / equity
10.42×
This company
0.62×
Market median
-1581% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GV Contact Person | Contact Person | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NAMSEN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gina Vivian Fjær | Contact Person | 0 companies |
| Nina Lian Ingebrigtsen | Board of Directors | 0 companies |
| Håvard Rein Solhaug | Board of Directors | 0 companies |
| Maria Michaela Lahner | Board of Directors | 0 companies |
| Siri Bjørlykke | Board of Directors | 0 companies |
| Andreas Rye | Chairman | 0 companies |
| Ida Kathrin Ingebrigtsen Welde | Board of Directors | 0 companies |